SAN FRANCISCO, June 22, 2016 /PRNewswire/ -- Amgen (AMGN) today announced a five-year, platinum sponsorship of the QB3@953 life sciences incubator to accelerate the development of new therapies to improve human health. The shared laboratory space at QB3@953 was created to help high-potential life science and biotech startups overcome a key obstacle for many early stage organizations - access to laboratory infrastructure.
Read more at finance.yahoo.com »